Amgen Inc.
AMGNAmgen Inc. (AMGN) is a Healthcare company that currently yields 2.38% — historically overvalued based on 10 years of dividend yield history. The Weiss valuation model places the undervaluation threshold at $268.94 and the overvaluation threshold at $342.05. Amgen Inc. holds a quality score of 67/100 (Good), reflecting 14 consecutive years of dividend growth with a 61% payout ratio. The 5-year dividend CAGR stands at 8.3%.
AMGN Dividend Yield History — Weiss Valuation
Distance to undervalued
Entry price is stretched
Needs 35.6% downside to reach the Weiss buy zone
Undervaluation starts near $268.94, where the annual dividend would imply roughly 3.70% yield. That is 1.31% above today's yield.
Buy-zone price
$268.94
Target yield
3.70%
Research checklist
What to clear before buying the yield
Updated Oct 1, 2026
Dividend durability
14YLong dividend history supports a deeper look.
Earnings payout
61%Earnings coverage leaves room for noise.
Cash payout
63%Free cash flow coverage supports the payment.
Dividend growth
8.3%Recent growth adds income compounding potential.
What changed
What changed since the last update
2026-09-30 → 2026-10-01
Price
-1.5%$423.64 → $417.42
Price fell 1.5% since the prior snapshot.
Why Now?
Amgen Inc. is trading near its historical overvaluation band.
Current yield 2.4% vs historical max 3.6% (66% of maximum).
14 consecutive years without a dividend cut.
Reasonable payout ratio of 61%.
What matters now
Read the signal before the headline yield
Valuation is the brake here: the yield is compressed versus its own history.
The 67/100 quality score calls for selective follow-up, not autopilot.
Start by checking whether payout coverage and business durability still support the dividend.
AMGN Dividend Income Projection — DRIP Compounder
Dividend Compounder (DRIP)
Year 1 Income
$258
Year 10 Income
$728
Yield on Cost
7.66%
Total Income
$4,501
Assumes dividends reinvested at current price. Simplified model — for illustrative purposes only.
Track actual vs. projected
See what AMGN dividends you actually received with Sharesight
Dividend income log · Yield on cost · DRIP cost basis · Tax reports
More research
Full price history & technical analysis
TradingView ↗Fundamentals, valuation & analyst ratings
FinViz ↗Moat rating & analyst fair value
Morningstar ↗Track dividends received & tax reports
Sharesight ↗AMGN Dividend Quality Score
Quality Score
Good
Key Metrics
Invest in AMGN
Check Amgen Inc. availability and current costs on eToro
Check eToro terms and availability →DividendVisual may earn a commission if you open an account via this link, at no cost to you. Capital at risk. Not financial advice.
In-depth analysis
→ AMGN Dividend Analysis Article